Total Payments
$8,776
2024 Payments
$887.84
Companies
21
Transactions
563
Medicare Patients
9,155
Medicare Billing
$509,520
Payment Breakdown by Category
Food & Beverage$8,695 (99.1%)
Education$80.58 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,695 | 557 | 99.1% |
| Education | $80.58 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,337 | 234 | $0 (2024) |
| PFIZER INC. | $1,338 | 97 | $0 (2024) |
| Abbott Laboratories | $772.39 | 24 | $0 (2023) |
| Amgen Inc. | $627.59 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $591.59 | 45 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $584.45 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $366.22 | 27 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $348.89 | 18 | $0 (2021) |
| iRhythm Technologies, Inc. | $197.70 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $175.43 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $887.84 | 45 | Novartis Pharmaceuticals Corporation ($404.50) |
| 2023 | $1,084 | 62 | Novartis Pharmaceuticals Corporation ($413.00) |
| 2022 | $1,104 | 57 | Novartis Pharmaceuticals Corporation ($302.86) |
| 2021 | $981.77 | 49 | Abbott Laboratories ($266.11) |
| 2020 | $742.62 | 47 | Novartis Pharmaceuticals Corporation ($306.37) |
| 2019 | $1,622 | 104 | Novartis Pharmaceuticals Corporation ($656.28) |
| 2018 | $1,222 | 100 | Novartis Pharmaceuticals Corporation ($487.56) |
| 2017 | $1,133 | 99 | Novartis Pharmaceuticals Corporation ($568.25) |
All Payment Transactions
563 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.33 | General |
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.46 | General |
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.53 | General |
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 06/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,100 | 2,771 | $302,695 | $110,147 |
| 2022 | 32 | 2,371 | 3,148 | $370,322 | $127,947 |
| 2021 | 32 | 2,499 | 3,207 | $405,840 | $144,137 |
| 2020 | 31 | 2,185 | 2,708 | $380,088 | $127,289 |
Total Patients
9,155
Total Services
11,834
Medicare Billing
$509,520
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2022 | 27 | 28 | $1,086 | $445.96 | 41.1% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2022 | 12 | 12 | $1,161 | $409.81 | 35.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2022 | 12 | 14 | $1,050 | $241.65 | 23.0% |
| 93279 | Programming of single lead pacemaker system | Office | 2022 | 11 | 11 | $699.00 | $239.75 | 34.3% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 11 | 11 | $1,154 | $140.79 | 12.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 12 | $300.00 | $138.40 | 46.1% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 15 | 17 | $935.00 | $135.95 | 14.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 13 | 15 | $686.00 | $34.33 | 5.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 519 | 756 | $86,184 | $35,683 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 265 | 331 | $56,270 | $21,679 | 38.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 95 | 195 | $25,125 | $10,337 | 41.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 63 | 71 | $25,264 | $10,264 | 40.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 70 | 135 | $24,360 | $10,218 | 41.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 127 | 132 | $42,360 | $10,208 | 24.1% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 98 | 98 | $15,920 | $5,711 | 35.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 90 | 95 | $13,395 | $5,015 | 37.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $12,267 | $4,592 | 37.4% |
| 75574 | Ct scan of heart blood vessels and grafts with contrast dye | Office | 2021 | 43 | 43 | $9,604 | $3,712 | 38.7% |
| 93280 | Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report | Office | 2021 | 108 | 113 | $8,758 | $3,176 | 36.3% |
| 93355 | Insertion of probe in esophagus for heart ultrasound examination during procedure on heart or great blood vessel via catheter | Facility | 2021 | 16 | 16 | $8,960 | $2,750 | 30.7% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 56 | 98 | $7,840 | $2,081 | 26.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 147 | 228 | $13,294 | $1,885 | 14.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2021 | 19 | 22 | $7,700 | $1,797 | 23.3% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 97 | 97 | $3,880 | $1,595 | 41.1% |
| 93284 | Evaluation, testing and programming adjustment of defibrillator with analysis, review and report, multiple lead defibrillator system | Office | 2021 | 34 | 35 | $4,760 | $1,587 | 33.3% |
About Dr. Charles Clogston, M.D
Dr. Charles Clogston, M.D is a Cardiovascular Disease healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962449728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Clogston, M.D has received a total of $8,776 in payments from pharmaceutical and medical device companies, with $887.84 received in 2024. These payments were reported across 563 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($8,695).
As a Medicare-enrolled provider, Clogston has provided services to 9,155 Medicare beneficiaries, totaling 11,834 services with total Medicare billing of $509,520. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology
- Location Little Rock, AR
- Active Since 06/01/2006
- Last Updated 03/24/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1962449728
Products in Payments
- ENTRESTO (Drug) $2,906
- ELIQUIS (Drug) $1,274
- Repatha (Biological) $627.59
- PRALUENT (Drug) $447.74
- LEQVIO (Drug) $430.93
- XARELTO (Drug) $366.22
- MITRACLIP (Device) $326.07
- VYNDAQEL (Drug) $294.57
- FARXIGA (Drug) $290.73
- MitraClip System (Device) $266.11
- CHANTIX (Drug) $226.14
- Mitra Clip system (Device) $155.70
- MULTAQ (Drug) $143.85
- ZIO Patch (Device) $136.77
- PRALUENT (Biological) $135.19
- CAMZYOS (Drug) $119.15
- NEXLETOL (Drug) $76.29
- ZIO XT Patch (Device) $47.31
- PRALUENT ALIROCUMAB INJECTION (Biological) $40.24
- BRILINTA (Drug) $38.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Little Rock
Ian Cawich, Md, MD
Cardiovascular Disease — Payments: $368,183
Cardiovascular Disease $368,183
Dr. Christian Assad-Kottner, Md, MD
Cardiovascular Disease — Payments: $263,227
Cardiovascular Disease $263,227
Muhammad Waqas, Md, MD
Cardiovascular Disease — Payments: $249,282
Cardiovascular Disease $249,282
Ernesto Ruiz-Rodriguez, M.d, M.D
Cardiovascular Disease — Payments: $160,407
Cardiovascular Disease $160,407
William Rollefson, Md, MD
Cardiovascular Disease — Payments: $157,519
Cardiovascular Disease $157,519
Andre Paixao, Md, MD
Cardiovascular Disease — Payments: $120,888
Cardiovascular Disease $120,888